MEGAN SCHMITZ: Open Payments
NPI 1205486206 · COLUMBIA CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 28 payments from 13 companies in 2025. Trend: 2023 $941 · 2024 $432 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $135 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Lilly USA, LLC | 2 | $58 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Exact Sciences Corporation | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: QULIPTA, JARDIANCE, AIRSUPRA, VRAYLAR, INSPIRE, Cologuard Collection Kit, Auvelity, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
